S49 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 41.8 EUR 1.95% Market Closed

Market Cap: €2.3B

S	Supernus Pharmaceuticals Inc F:S49	US
B	Bunge Ltd F:BU3	US
K	Kosmos Energy Ltd F:KOS1	US
	CareCloud Inc F:MTB0	US
B	Britania PCL SET:BRI	TH
R	Realord Group Holdings Ltd F:CUV	HK
	Promotora y Operadora de Infraestructura SAB de CV F:AKY	MX
W	Westpac Banking Corp SWB:WBC	AU

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

86% > 90%

Negative Operating Margin

-8%

Low 3Y Average Operating Margin

Declining Operating Margin

7% > -8%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

8% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.